Moderna, Inc. Earnings Per Share, Basic and Diluted
Moderna, Inc. (MRNA) reported Earnings Per Share, Basic and Diluted of -$1.96 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-02-26
- Moderna, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.59.
- Moderna, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.31.
- Moderna, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.35.
- Moderna, Inc. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.37.
- Moderna, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.96.
- Moderna, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.55.
- Moderna, Inc. earnings per share, basic and diluted for fiscal 2018 was -$4.95.
- Moderna, Inc. earnings per share, basic and diluted for fiscal 2017 was -$4.18.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$1.96 10-K · filed 2021-02-26 | |||
| 2020-09-30 | -$0.59 10-Q · filed 2020-10-30 | -$1.26 10-Q · filed 2020-10-30 | ||
| 2020-06-30 | -$0.31 10-Q · filed 2020-08-06 | -$0.66 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | -$0.35 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | -$0.37 10-K · filed 2020-02-27 | -$0.74 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.15 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.55 10-K · filed 2021-02-26 |
| 2019-09-30 | -$0.37 10-Q · filed 2020-10-30 | -$0.78 derived: net income ÷ weighted average shares · filed 2020-10-30 | -$1.19 10-Q · filed 2020-10-30 | -$1.92 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-06-30 | -$0.41 10-Q · filed 2020-08-06 | -$0.81 10-Q · filed 2020-08-06 | -$1.57 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.35 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-03-31 | -$0.40 10-Q · filed 2020-05-07 | -$1.21 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$2.10 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$3.12 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2018-12-31 | -$1.14 10-K · filed 2020-02-27 | -$2.40 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$3.78 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$4.95 10-K · filed 2021-02-26 |
| 2018-09-30 | -$1.32 10-K · filed 2020-02-27 | -$2.75 derived: net income ÷ weighted average shares · filed 2019-11-06 | -$3.91 10-Q · filed 2019-11-06 | |
| 2018-06-30 | -$1.43 10-K · filed 2020-02-27 | -$2.59 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$1.16 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$0.64 10-K · filed 2019-03-13 | -$4.18 10-K · filed 2020-02-27 | ||
| 2017-09-30 | -$1.05 10-K · filed 2019-03-13 | |||
| 2017-06-30 | -$1.47 10-K · filed 2019-03-13 | |||
| 2017-03-31 | -$1.03 10-K · filed 2019-03-13 | |||
| 2016-12-31 | -$3.79 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |